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Abstract
Background: The emergence and spread of multidrug resistant methicillin-resistant Staphylococcus aureus (MDR-
MRSA) has serious health consequences in the presence of sub-MIC antibiotics. Therefore, this study was designed
to evaluate β-lactamase activity, efflux activity, biofilm formation, and gene expression pattern in Staphylococcus
aureus KACC 10778, S. aureus ATCC 15564, and S. aureus CCARM 3080 exposed to sublethal concentrations of
levofloxacin and oxacillin.
Results: The decreased MICs were observed in S. aureus KACC and S. aureus ATCC when exposed to levofloxacin
and oxacillin, while and S. aureus CCARM remained resistance to streptomycin (512 μg/mL) in the presence of
levofloxacin and imipenem (>512 μg/mL) in the presence of oxacillin. The considerable increase in extracellular and
membrane-bound β-lactamase activities was observed in S. aureus ATCC exposed to oxacillin (>26 μmol/min/mL).
The antibiotic susceptibility of all strains exposed to EPIs (CCCP and PAβN) varied depending on the classes of
antibiotics. The relative expression levels of adhesion-related genes (clfA, clfB, fnbA, fnnB, and icaD), efflux-related
genes (norB, norC, and qacA/B), and enterotoxin gene (sec) were increased more than 5-fold in S. aureus CCARM.
The eno and qacA/B genes were highly overexpressed by more than 12- and 9-folds, respectively, in S. aureus
CCARM exposed to levofloxacin. The antibiotic susceptibility, lactamase activity, biofilm-forming ability, efflux
activity, and gene expression pattern varied with the intrinsic antibiotic resistance of S. aureus KACC, S. aureus
ATCC, and S. aureus CCARM exposed to levofloxacin and oxacillin.
Conclusions: This study would provide useful information for better understating of combination therapy related
to antibiotic resistance mechanisms and open the door for designing effective antibiotic treatment protocols to
prevent excessive use of antibiotics in clinical practice.
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Background
Over the last several decades, the overuse and misuse of
broad-spectrum antibiotics has contributed to the in-
creased emergence of antibiotic resistant pathogens such
as methicillin-resistant Staphylococcus aureus (MRSA)
[1, 2]. MRSA infections can cause mild to severe diseases,
including skin lesion, toxic shock syndrome, endocarditis,
osteomyelitis, and meningitis [2, 3]. Both hospital-acquired
MRSA and community-acquired MRSA have currently
become the leading causes of morbidity and mortality
worldwide [3, 4]. Furthermore, MRSA can develop co-
resistance to different classes of antibiotics, including fluor-
oquinolones, aminoglycosides, macrolides, tetracyclines,
and β-lactams, known as multidrug resistant (MDR) MRSA
[5–7]. The MDR-MRSA can frequently be exposed to
subinhibitory concentrations of antibiotics, which leads to
gene transfer, biofilm formation, and virulence gene expres-
sion [1]. The emergence and spread of MDR-MRSA has
serious health consequences in the presence of sub-MIC
antibiotics. Therefore, the effective control of MDR-
MRSA is a research priority in hospitals and other health-
care facilities.
The different classes of antibiotics are used to improve
the treatment of MDR bacterial infections, specifically
carbapenem-resistant Enterobacteriaceae (CRE), which is
known as combination therapy [8]. The benefits of using
the combination therapy include the extension of
antibiotic spectrum, synergistic enhancement of anti-
biotic activity, and decrease in the frequency of anti-
biotic resistance [8, 9]. Compared to the mono-therapy,
the combination therapy can reduce the excessive use of
antibiotics. However, controversially, there are also risks
associated with the combination therapy. The selection
of antibiotic resistance varies depending on the concen-
trations exposed to antibiotics [10]. Bacteria exposed to
sublethal concentrations are likely to have a wide range
of mutation variance compared to those exposed to
lethal concentrations of antibiotics [1]. Relatively, few
studies have investigated the mechanisms of resistance
in MRSA under combination therapy. Therefore, in this
study, we evaluated the physiological and molecular
responses of MRSA to different classes of antibiotics in
the presence of oxacillin and levofloxacin as measured
by β-lactamase activity, efflux activity, biofilm formation,
and gene expression pattern.
Methods
Bacterial strains and culture conditions
Strains of S. aureus KACC 10778, S. aureus ATCC
15564, and S. aureus CCARM 3080 were obtained from
American Type Culture Collection (ATCC, Manassas,
VA), Korean Agricultural Culture Collection (KACC,
Suwon, Korea), and Culture Collection of Antibiotic Re-
sistant Microbes (CCARM, Seoul, Korea), respectively.
All strains were cultured in tryptic soy broth (TSB;
BD, Becton, Dickinson and Co., Sparks, MD) at 37 °C
for 20 h. After cultivation, cultures were centrifuged at
3000 × g for 20 min at 4 °C, washed twice with
phosphate-buffered saline (PBS, pH 7.2), and then
used for assays.
Single antibiotic susceptibility assay
The susceptibility of S. aureus KACC 10778, S. aureus
ATCC 15564, and S. aureus CCARM 3080 to each anti-
biotic listed in Additional file 1: Table S1 was evaluated
according to the Clinical Laboratory Standards Institute
(CLSI) procedure with minor modification [11]. All anti-
biotic stock solutions were prepared by dissolving in
distilled water (ampicillin, cefoxitin, ceftazidime, ceftri-
axone, gentamicin, meropenem, oxacillin, streptomycin,
and vancomycin), ethaol (chloramphenicol and tetracyc-
line), glacial acetic acid (ciprofloxacin, levofloxacin, and
norfloxacin), dimethyl sulfoxide (DMSO; imipenem) to
obtain a final concentration of 10.24 mg/mL. Each stock
solution (100 μL) was serially (1:2) diluted from 512 μg/
mL with TSB in 96-well microtiter plates (BD Falcon,
San Jose, CA). All strains were inoculated at a level of
106 CFU/mL and incubated at 37 °C for 18 h. Mini-
mum inhibitory concentration (MIC) was determined
at the lowest concentration of each antibiotic at which
there is no visible growth. MIC breakpoints were used
to define susceptible (S), intermediate (I), and resistant
(R) strains [12, 13].
Combination antibiotic sensitivity test
The susceptibility of S. aureus KACC 10778, S. aureus
ATCC 15564, and S. aureus CCARM 3080 to each anti-
biotic was also evaluated in the presence of oxacillin or
levofloxacin. All strains (105 CFU/mL each) were inoc-
ulated in 96-well microtiter plates containing serial
(1:2) antibiotic dilutions and basal antibiotic (oxacillin
or levofloxacin; 1/2 MIC). MICs were determined as
above mentioned.
β-lactamase activity assay
The ability of β-lactamase to hydrolyze nitrocefin was
evaluated by using a spectrophotometric assay with
minor modifications [14]. S. aureus KACC 10778, S.
aureus ATCC 15564, and S. aureus CCARM 3080 cells
exposed to 1/2 MIC of oxacillin or levofloxacin at 37 °C
for 20 h were centrifuged at 3000 × g for 20 min at 4 °C.
The cells suspended in PBS and cell-free supernatants
were mixed with 20 μL of 1.5 mM nitrocefin and incu-
bated at 37 °C for 30 min. The absorbance was mea-
sured every 5 min at 515 nm [15].
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Ethidium Bromide (EtBr) cartwheel method
The cultured strains were centrifuged and then rinsed
with PBS. The harvested cells were suspended in PBS
with and without EPIs (CCCP, 0.5 μg/mL; PAβN, 8 μg/
mL) [16, 17]. TSA plates containing EtBr (1 μg/mL)
were prepared under darkness and divided into 9 sectors
with cartwheel pattern. The prepared cells were swabbed
on EtBr-agar plates and then incubated at 37 °C for
16 h. After incubation, the swabbed EtBr-agar plates
were observed under UV illumination (Gel-doc XR Sys-
tem; Bio-Rad, Hertfordshire, UK).
Competitive efflux pump inhibition assay
The efflux pump activity of S. aureus KACC 10778, S. aur-
eus ATCC 15564, and S. aureus CCARM 3080 was evalu-
ated in the absence and presence of efflux pump
inhibitors (EPIs), carbonyl cyanide-m-chlorophenyl hydra-
zone (CCCP) and phenylalanine-arginine-β-naphthyla-
mide (PAβN). The changes in antibiotic susceptibility of S.
aureus ATCC 15564, S. aureus KACC 10778, and S. aur-
eus CCARM 3080 exposed to EPIs were determined as
above mentioned.
Biofilm-forming ability assay
The biofilm formation potential by S. aureus KACC
10778, S. aureus ATCC 15564, and S. aureus CCARM
3080 was evaluated in the absence and presence of oxa-
cillin or levofloxacin, which was based on the ability of
strains to attach on 12-well polystyrene microtiter plate
surface. All strains (106 CFU/mL each) were inoculated
in TSB containing 1/2 MIC of oxacillin or levofloxacin
and incubated at 37 °C for 24 h. After cultivation, each
well was gently washed with PBS to remove loosely
adhered cells. The adhered cells were harvested by using
a cell scraper (Thermo Scientific Nunc, Rochester, NY).
The collected cells were dispersed in PBS (1 mL) and then
serially diluted (1:10) with PBS. The proper dilutions were
plated on trypticase soy agar (TSA) using an Autoplate
Spiral Plating System (Spiral Biotech Inc., Norwood, MA,
USA). The plates were incubated at 37 °C for 24–48 h to
enumerate adhered cells using a QCount Colony Counter
(Spiral Biotech Inc.).
Quantitative PCR assay
The RNA extraction was carried out using RNeasy
Protect Bacteria Mini kit (Qiagen, Hilden, Germany).
Briefly, S. aureus KACC 10778, S. aureus ATCC 15564,
and S. aureus CCARM 3080 cells (0.5 mL each) exposed
to 1/2 MIC of oxacillin or levofloxacin at 37 °C for 20 h
were mixed with 1 ml of RNAprotect Bacteria Reagent.
The mixtures were centrifuged at 5000 × g for 10 min,
and the collected cells were lysed with a buffer contain-
ing lysozyme. The lysates were mixed with ethanol to
extract RNA using an RNeasy mini column. In order to
synthesize cDNA, the RNA extracts were rinsed with a
Wipe buffer to remove the genomic DNA and then
mixed a master mixture of reverse transcriptase, RT buf-
fer, and RT primer mix and then incubated at 42 °C for
15 min followed by 95 °C for 3 min. The PCR mixture
(20 μl) containing 10 μl of 2× QuantiTect SYBR Green
PCR Master, 2 μl of each primer, and 2 μl of cDNA, and
4 μl of RNase-free water was denatured at 95 °C for
30 s, followed by 45 cycles of 95 °C for 5 s, 55 °C for
20 s, and 72 °C for 15 s using an iCycler iQ™ system
(Bio-Rad Laboratories, Hemel Hempstead, UK). The
custom-synthesized oligonucleotides using IDT (Inte-
grated DNA Technologies Inc., Coralville, IA, USA) as
primers of S. aureus are listed in Additional file 2: Table S2.
The relative gene expression levels were estimated using
the comparative method [18]. The CT values of target genes
in S. aureus KACC 10778, S. aureus ATCC 15564, and S.
aureus CCARM 3080 cells exposed to 1/2 MIC of oxacillin
or levofloxacin were compared to the CT values obtained
from the control cells, respectively. The reference gene
(16S ribosomal RNA) was used for normalization of target
gene expression.
Statistical analysis
Data were analyzed by the Statistical Analysis System
(SAS) software. All analyses were carried out in dupli-
cate for three replicates. The general linear model
(GLM) and Fisher’s least significant difference (LSD)
procedures were used to determine significant mean dif-
ferences at p < 0.05.
Results
Antibiotic susceptibility of S. aureus
The MICs of selected antibiotic against S. aureus KACC
10778, S. aureus ATCC 15564, and S. aureus CCARM
3080 were determined in absence and presence of antibi-
otics (levofloxacin and oxacillin) (Table 1). S. aureus
KACC 10778, S. aureus ATCC 15564, and S. aureus
CCARM 3080 were classified on the basis of MIC break-
points as antibiotic-sensitive, intermediate, and antibiotic-
resistant strains, respectively. S. aureus KACC 10778 and
S. aureus ATCC 15564 were relatively sensitive to most
antibiotics when compared to S. aureus CCARM 3080
which was resistant to all antibiotics with the exception of
chloroamphenicol and vancomycin. The MIC values of
most antibiotics against all strains tested were decreased
in the presence of levofloxacin and oxacillin. However, no
changes were observed in susceptibilities of S. aureus
KACC 10778 to chloramphenicol when exposed to levo-
floxacin, gentamicin exposed to oxacillin, tetracycline
exposed to levofloxacin and oxacillin and S. aureus ATCC
15564 to ceftazidime exposed to levofloxacin and tetracyc-
line exposed to levofloxacin and oxacillin. The reduced
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susceptibility of S. aureus CCARM 3080 to streptomycin
was observed in the presence of levofloxacin.
Lactamase activity
The extracellular and membrane-bound β-lactamase
activities were measured in S. aureus KACC 10778, S. aur-
eus ATCC 15564, and S. aureus CCARM 3080 exposed to
levofloxacin and oxacillin. No significant change in β-
lactamase activities was observed in S. aureus KACC
10778 and S. aureus CCARM 3080 exposed to levofloxa-
cin. The highest extracellular and membrane-bound β-
lactamase activities were observed in S. aureus ATCC
15564 exposed to oxacillin, increased to 33 and 26 μmol/
min/mL, respectively (Fig. 1).
Efflux activity
The efflux activity of S. aureus KACC 10778, S. aureus
ATCC 15564, and S. aureus CCARM 3080 was evaluated
on TSA agar plates containing EtBr (Fig. 2). The level of
fluorescence intensity was increased in S. aureus ATCC
15564 exposed to CCCP and PAβN compared to the
control. The highest efflux activity was observed in S.
aureus CCARM 3080 regardless of the presence of efflux
pump inhibitors. The role of efflux pumps in the anti-
biotic resistance was evaluated in S. aureus KACC
10778, S. aureus ATCC 15564, and S. aureus CCARM
3080 exposed to efflux pump inhibitors, CCCP and
PAβN (Fig. 3). The antibiotic susceptibility patterns of
all strains exposed to efflux pump inhibitors varied in
the types of antibiotics. The antibiotic activity of imipe-
nem against S. aureus KACC 10778 was increased in the
Table 1 MIC (μg/mL) of selected antibiotics against Staphylococcus aureus in a half MIC of levofloxacin (LVX) or oxacillin (OXA)
Antibiotic S. aureus KACC 10778 S. aureus ATCC 15564 S. aureus CCARM 3080
Control LVX OXA Control LVX OXA Control LVX OXA
Ampicillin 0.25(S) 0.125 0.25 32(R) 8 4 256(R) <1 16
Cefoxitin 2(S) 0.5 0.5 4(S) 1 0.25 >512(R) <1 32
Ceftazidime 8(R) 2 4 16(R) 16 4 512(R) 4 128
Ceftriaxone 2(R) 1 1 4(R) 1 0.25 >512(R) <2 512
Chloramphenicol 8(S) 8 4 8(S) 4 4 16(I) 4 8
Ciprofloxacin 0.5(S) 0.125 0.25 0.5(S) 0.25 0.125 32(R) 1 8
Gentamicin 1(S) 0.5 1 16(R) 2 1 >512(R) 128 256
Imipenem 2(S) 1 1 0.25(S) 1 1 >512(R) 8 >512
Levofloxacin 0.25(S) – 0.125 0.25(S) – 0.0625 32(R) – 4
Meropenem 0.125(S) 0.0313 0.0313 0.125(S) 0.0625 0.0313 64(R) <1 8
Norfloxacin 2(S) 0.5 1 1(S) 0.5 0.5 32(R) 2 8
Oxacillin 0.25(S) 0.0625 – 0.25(S) 0.125 – >512(R) <1 –
Streptomycin 8(R) 4 4 64(R) 32–16 4 128(R) 512 4
Tetracycline 0.5(S) 0.5 0.5 0.25(S) 0.25 0.25 64(R) 16 32




































































Fig. 1 Hydrolyzing activity of extracellular β-lactamase a and
membrane-bound β-lactamase b produced by Staphylococcus aureus
KACC 10778, S. aureus ATCC 15564, and S. aureus CCARM 3080 exposed
to a half MIC of oxacillin or levofloxacin. Means with different letters (a–c)
on the bars are significantly different at p< 0.05
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presence of efflux pump inhibitors, whereas the resist-
ance of S. aureus KACC 10778 to streptomycin and
tetracycline was increased in the presence of efflux
pump inhibitors. The sensitivity of S. aureus ATCC
15564 to ampicillin, ciprofloxacin, and imipenem was
increased in the presence of CCCP and PAβN. The sen-
sitivity of S. aureus CCARM 3080 to imipenem, oxacil-
lin, and streptomycin was increased in the presence of
CCCP and PAβN.
Biofilm-forming ability
The biofilm-forming ability of S. aureus KACC 10778,
S. aureus ATCC 15564, and S. aureus CCARM 3080
was evaluated in the presence of levofloxacin and oxa-
cillin (Fig. 4). Compared to the control, the number of
biofilm-forming cells of S. aureus KACC 10778 was re-
duced by approximately 2 log CFU/mL in the presence
of oxacillin, whereas those of S. aureus ATCC 15564
and S. aureus CCARM 3080 were reduced by 0.5-1 log
CFU/mL in the presence of levofloxacin and oxacillin.
Differential gene expression
The relative expression of adhesion-related genes (clfA, clfB,
eno, fib, fnbA, fnnB, and icaD), efflux-related genes (mdeA,
norB, norC, and qacA/B), and enterotoxin gene (sec) were
observed in S. aureus KACC 10778, S. aureus ATCC
15564, and S. aureus CCARM 3080 grown in the absence
and presence of levofloxacin and oxacillin (Fig. 5). The rela-
tive expression levels of most selected genes were increased
more than 5-fold in antibiotic-resistant S. aureus CCARM
3080 (Fig. 5a). The clfB, fnbB, norB, and qacA/B genes were
overexpressed in S. aureus KACC 10778 grown in the pres-
ence of oxacillin (>3-fold), whereas the relative expression
levels of eno, icaA, and icaD were decreased more than 5-
fold in both levofloxacin and oxacillin (Fig. 5b). Most of
genes in S. aureus ATCC 15564 were slightly overexpressed
in the presence of levofloxacin and oxacillin (Fig. 5c). As
shown in Fig. 5d, the eno and qacA/B genes were overex-
pressed by more than 12- and 9-fold, respectively, in S. aur-
eus CCARM 3080 grown in the presence of levofloxacin.
The norB was slightly overexpressed in S. aureus CCARM
3080 grown in the presence of levofloxacin and oxacillin.
Fig. 2 Accumulation and efflux activity of Staphylococcus aureus
KACC 10778, S. aureus ATCC 15564, and S. aureus CCARM 3080 on












































































































































































Staphylococcus aureus KACC 10778





































































































Staphylococcus aureus ATCC 15564 
Fig. 3 Antibiotic susceptibility of Staphylococcus aureus KACC 10778, S. aureus ATCC 15564, and S. aureus CCARM 3080 in the absent (○) and present
of efflux pump inhibitors, CCCP (Δ) and PAβN (□)
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Discussion
This study describes the antibiotic susceptibility and
gene expression dynamics of S. aureus with different
antibiotic resistance profiles when exposed to sub-MICs
of levofloxacin and oxacillin. As antibiotic-resistant
pathogens are frequently exposed to sublethal concen-
trations of antibiotic prescribed in hospitals, this study
sheds light on the understanding of antibiotic resistance
mechanisms and the effectiveness of combination ther-
apy. This study investigated the relationship between
phenotypic and genotypic properties of S. aureus KACC
10778, S. aureus ATCC 15564, and S. aureus CCARM
3080 exposed to a half MIC of levofloxacin or oxacillin.
The susceptibilities of S. aureus KACC 10778, S. aur-
eus ATCC 15564, and S. aureus CCARM 3080 to most
antibiotics were increased in the presence of levofloxacin
and oxacillin, whereas no difference in the susceptibil-
ities of S. aureus KACC 10778, S. aureus ATCC 15564,
and S. aureus CCARM 3080 to ceftazidime, chloram-
phenicol, gentamicin, and vancomycin were observed in
the presence of levofloxacin and oxacillin (Table 1). S.
aureus CCARM 3080 showed the decreased susceptibil-
ity to streptomycin. This is in good agreement with a
previous report that MRSA exhibited the enhanced re-
sistance to other classes of antibiotics, leading to multi-
drug resistance [19]. Compared to S. aureus KACC
10778 and S. aureus ATCC 15564, the decreased oxacil-
lin susceptibility was observed in S. aureus CCARM
3080 (MIC > 512 μg/mL), which may be attributed to
the activation of penicillin-binding protein (PBP2a)
encoded by mecA, but not due to the activation of β-
lactamase [20, 21]. MRSA can acquire additional resist-
ance to ciprofloxacin, causing a frequent failure in
antibiotic treatment [6]. The successive antibiotic treat-
ment may be not effective against bacterial infections
because of the increase in bacterial adaptation to initial
antibiotic exposure. Thus, the combination therapy is
commonly used to broaden antibiotic spectrum and
achieve synergistic effect in life-threatening infections [8,
9, 22]. As shown in Table 1, S. aureus CCARM 3080
exposed to levofloxacin was more susceptible to most
classes of antibiotics than that exposed to oxacillin with
the exception of streptomycin and vancomycin. Interest-
ingly, the susceptibility of S. aureus CCARM 3080 to
streptomycin, however, was decreased in the presence of
levofloxacin. The combination therapy can lead to cross-
resistance to different classes of antibiotics. The anti-
biotic susceptibility of S. aureus KACC 10778, S. aureus
ATCC 15564, and S. aureus CCARM 3080 exposed to
levofloxacin and oxacillin depends on the additional
resistance mechanisms. Therefore, the systematic inves-
tigation is needed to understand the mechanisms under-
lying cross-resistance in combination therapy.
The extracellular and membrane-bound β-lactamase
activities were influenced by the intrinsic antibiotic resist-
ance of S. aureus KACC 10778, S. aureus ATCC 15564,
and S. aureus CCARM 3080 when exposed to levofloxacin
and oxacillin. The production of β-lactamase was consid-
erably increased in S. aureus ATCC 15564 when exposed
to oxacillin, suggesting that the stabilities of β-lactam anti-
biotics were enhanced against staphylococcal β-lactamases
(Fig. 1). Methicillin, oxacillin, cephalothin are less sus-
ceptible to hydrolysis by staphylococcal β-lactamases
[23]. The resistance of S. aureus KACC 10778, S. aur-
eus ATCC 15564, and S. aureus CCARM 3080 to β-
lactam antibiotics may be associated with low-affinity
PBPs and membrane permeability [21, 23, 24]. On the
other hand, the results imply that the inappropriate se-
lection of antibiotics for combination therapy can lead
to the induction of β-lactamases.
S. aureus KACC 10778 exhibited low efflux activity in
the absence and presence of inhibitors (CCCP and PAβN),
whereas the efflux activity of S. aureus ATCC 15564 was
effectively inhibited by CCCP and PAβN (Fig. 2). The
highest efflux activity was observed in S. aureus CCARM
3080, which was not even reduced by efflux pump inhibi-
tors. This suggests that there exist the inhibitor-insensitive
efflux pump systems in S. aureus CCARM 3080, resulting
in multidrug resistance. The enhanced efflux activity is a
main cause of multidrug resistance in S. aureus CCARM
3080 [17].
S. aureus KACC 10778, S. aureus ATCC 15564, and S.
aureus CCARM 3080 were exposed to efflux pump in-
hibitors to characterize the substrate specificity of multi-
drug efflux pumps (Fig. 3). The MICs of imipenem against
S. aureus KACC 10778, ampicillin, ciprofloxacin, and imi-
penem against S. aureus ATCC 15564, and imipenem,
oxacillin, and streptomycin against S. aureus CCARM 3080
































Fig. 4 Biofilm-forming ability of Staphylococcus aureus grown in a
half MIC of oxacillin or levofloxacin. Log reduction was estimated as
compared to the control. Means with different letters (a–b) on the
bars are significantly different at p < 0.05
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inhibitors (CCCP and PAβN), suggesting the antibiotic re-
sistance is associated with the proton motive force and sub-
strate competition-dependent efflux systems [25]. The
plasma membrane is depolarized in the presence of CCCP,
which collapses proton electrochemical gradient [25].
PAβN, a substrate of efflux pumps, acts as an inhibitor
competing with antibiotics [14]. The antibiotics inducing
PAβN-susceptible efflux can act as potential competitors
for multidrug efflux pump systems. The multidrug resist-
ance in bacteria is directly related to the activity of efflux
pumps [26, 27]. The reduced susceptibility to the different

































































Fig. 5 Relative gene expression in antibiotic-resistant strains (S. aureus ATCC 15564 and S. aureus CCARM 3080) grown in the absence of oxacillin and
levofloxacin a and S. aureus KACC 10778 b, S. aureus ATCC 15564 c, and S. aureus CCARM 3080 d grown in a half MIC of oxacillin or levofloxacin
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was due to the interacting resistance mechanisms. As
shown in Fig. 3, the MICs of ceftazidime to all strains
tests were increased in the presence of PAβN, which
corresponds to Table 1 and Fig. 3. The efflux pumps
are stimulated by β-lactams. The efflux-mediated anti-
biotic resistance mechanism can affect the β-lactam
uptake, resulting in the increase in β-lactam suscepti-
bility [24]. In contrast, no changes in antibiotic
susceptibility between absence and presence of efflux
pump inhibitors were observed in S. aureus KACC
10778 (ciprofloxacin, levofloxacin, meropenem, and
oxacillin), S. aureus ATCC 15564 (levofloxacin and
meropenem), and S. aureus CCARM 3080 (ciprofloxa-
cin and levofloxacin). The observations imply that there
are various types of efflux pump systems in S. aureus
KACC 10778, S. aureus ATCC 15564, and S. aureus
CCARM 3080 [28]. Unlike PAβN, CCCP can decrease the
accumulation of antibiotics, resulting in the elevated MICs
in S. aureus KACC 10778 (ampicillin and streptomycin),
S. aureus ATCC 15564 (ampicillin and oxacillin), and S.
aureus CCARM 3080 (ampicillin, imipenem, meropenem,
and oxacillin) [28].
The reduction in the number of biofilm cells was more
noticeable in S. aureus KACC 10778 exposed to oxacillin
than the multiple antibiotic-resistant S. aureus ATCC
15564 and S. aureus CCARM 3080 (Fig. 4). The antibiotic-
resistant strains are more likely to obtain cross-protection
against various stresses such as acid, heat, and antibiotics
[29]. The exposure to certain antibiotics can positively asso-
ciated with the formation of bacterial biofilms [30]. The
degree of biofilm formation depends on the type of antibi-
otics, including biofilm-inducing (ampicillin, vancomycin,
and ceftizoxime) and biofilm-noninducing antibiotics
(gentamycin) [30]. The enhanced resistance of biofilms
to environmental stresses and antibiotics play an im-
portant role in the pathogenesis of bacterial infections
[31]. Therefore, the combination therapy needs to take
into account the risk factors for multiple antibiotic-
resistant bacterial infections.
Most of the overexpressed adhesion-, efflux pump-, and
enterotoxin genes were observed in S. aureus CCARM
3080 compared to S. aureus KACC 10778 (Fig. 5a). The
increased expression levels of adhesion-related genes in S.
aureus ATCC 15564 and S. aureus CCARM were directly
related to the enhanced biofilm-forming ability [32]. The
genes encoding clumping factor, laminin-, and fibronectin-
binding proteins were overexpressed in S. aureus ATCC
15564 and S. aureus CCARM when exposed to levofloxacin
and oxacillin, suggesting sublethal concentrations of antibi-
otics can improve the surface adhesion properties of bac-
teria [1]. The increased resistance of S. aureus CCARM
3080 to multiple antibiotics may be mediated by the
overexpression of mdeA, norB, norC, and qacA/B genes
[33–36]. The expression level of sec gene was increased
more than 20-fold in S. aureus CCARM 3080, suggesting
that staphylococcal enterotoxin can be a major cause of
staphylococcal infections [37]. Most genes were overex-
pressed in resistance strains (S. aureus ATCC 15564 and S.
aureus CCARM) when exposed to levofloxacin and oxacil-
lin (Fig. 5c-d). The multidrug resistance of S. aureus ATCC
15564 and S. aureus CCARM was attributed to the overex-
pression of efflux pump-related genes (mdeA, norB, norC,
and qacA/B) [17]. However, the different expression levels
of genes encoding efflux pump system in S. aureus KACC
10778, S. aureus ATCC 15564, and S. aureus CCARM
3080 were observed between exposures to levofloxacin and
oxacillin. The expression of efflux pump-related genes is
induced depending on the exposure to different classes of
antibiotics as substrates. Ciprofloxacin is a common sub-
strate of efflux pump systems (NorA, NorB, and NorC) and
cationic lipophilic drugs are preferential substrates of
QacA/B, a major facilitator superfamily (MFS) [38, 39].
MRSA carries qacA and qacB in higher rate than MSSA
[36]. Kanamycin, linezolid, and lincomycin are the sub-
strates of LmrS multidrug efflux pump, which is similar to
EmrB of Escherichia coli and FarB of Neisseria gonorrhoeae
[7]. The major substrate of MdeA multidrug efflux pump is
norfloxacin [39]. Tetracycline, fluoroquinolone, and macro-
lides are the substrates of TetA(K), SdrM, and Mdf(A)
efflux pump systems, respectively [39, 40]. The overexpres-
sion of the efflux pump systems contributes to the en-
hanced resistance to their substrates. Bacteria exposed to
sublethal concentration can become resistant to multiple
antibiotics in a high frequency, whereas lethal concentra-
tions can induce single mutation [1]. Therefore, a proper
combination therapy needs to be designed on the basis of
antibiotic resistance mechanisms and profiles of target
pathogens, which can increase the susceptibility to combin-
ation therapy and prevent the spread of newly acquired
antibiotic resistance.
Conclusions
This study highlights the varied and interactive charac-
teristics of antibiotic resistance in S. aureus KACC 107
78, S. aureus ATCC 15564, and S. aureus CCARM 3080
exposed to sub-MICs of levofloxacin and oxacillin. The
phenotypic and genotypic properties of S. aureus with
different antibiotic resistance profiles varied in terms of
lactamase activity, efflux activity, biofilm-forming ability,
and gene expression pattern. The antibiotic-resistant S.
aureus can acquire cross resistance between different
classes of antibiotics when exposed to sublethal concen-
tration, ascribed to differential activity of β-lactamase
and efflux pump systems. The results obtained in this
study indicate that monitoring antibiotic susceptibility
patterns is essential to effectively treat antibiotic-
resistant bacterial infections in case of continuous anti-
biotic exposure, and appropriate combination therapy is
Jo and Ahn BMC Microbiology  (2016) 16:170 Page 8 of 10
required in treating pathogens with different levels of
antibiotic resistance. In addition, the characteristic
changes in phenotypic and genotypic expression can be
used to accurately detect antibiotic-resistant bacteria,
which plays an important role in designing antibiotic
treatment plan and developing new diagnostic technique
for antibiotic resistance. Further systematic studies taking
into account molecular approaches are needed to demon-
strate the multiple antibiotic resistance mechanisms of
pathogens exposed to various antibiotics through combin-
ation therapy.
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